Zobrazeno 1 - 10
of 296
pro vyhledávání: '"Annarosa Floreani"'
Autor:
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101168- (2024)
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known
Externí odkaz:
https://doaj.org/article/8d1c44ac78ae4a3ebc2eca8571c39ace
Publikováno v:
Life, Vol 14, Iss 4, p 500 (2024)
Gender Medicine has had an enormous expansion over the last ten years. Autoimmune liver diseases include several conditions, i.e., autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and conditions inv
Externí odkaz:
https://doaj.org/article/3fcdc12223e849a4bda36ad7c312bb99
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2194 (2024)
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterised by the immune-mediated destruction of small and medium intrahepatic bile ducts, with variable outcomes and progression. This review summarises the state of the art regardi
Externí odkaz:
https://doaj.org/article/5d8105cc229a4e5fb77d444d558bee31
Autor:
Diletta Overi, Guido Carpino, Laura Cristoferi, Paolo Onori, Lindsey Kennedy, Heather Francis, Nicola Zucchini, Cristina Rigamonti, Mauro Viganò, Annarosa Floreani, Daphne D’Amato, Alessio Gerussi, Rosanna Venere, Gianfranco Alpini, Shannon Glaser, Domenico Alvaro, Pietro Invernizzi, Eugenio Gaudio, Vincenzo Cardinale, Marco Carbone
Publikováno v:
JHEP Reports, Vol 4, Iss 11, Pp 100556- (2022)
Background & Aims: Primary biliary cholangitis (PBC) is a chronic cholangiopathy characterised by immuno-mediated injury of interlobular bile ducts leading to intrahepatic cholestasis and progressive liver fibrosis. PBC histology is characterised by
Externí odkaz:
https://doaj.org/article/d0606557065e42109cd7f0e8e0b8838f
Autor:
Alessio Gerussi, Cristina Rigamonti, Chiara Elia, Nora Cazzagon, Annarosa Floreani, Roberta Pozzi, Pietro Pozzoni, Ernesto Claar, Luisa Pasulo, Stefano Fagiuoli, Laura Cristoferi, Marco Carbone, Pietro Invernizzi
Publikováno v:
Hepatology Communications, Vol 4, Iss 9, Pp 1257-1262 (2020)
Chronic immunosuppression is associated with increased and more severe viral infections. However, little is known about the association between immunosuppression and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Our aim
Externí odkaz:
https://doaj.org/article/9301c1daecb941f99920019b3909076e
Autor:
Valentina Cossiga, Nora Cazzagon, Roberto Montalti, Stefania Ciminnisi, Maria Rosaria Attanasio, Francesco Pezzato, Marco Giacchetto, Maria Guarino, Vincenza Calvaruso, Annarosa Floreani, Filomena Morisco
Publikováno v:
Digestive and Liver Disease. 55:778-784
Background and aim: Metabolic dysfunctions, particularly hyperlipidemia, are a common finding in Primary Biliary Cholangitis (PBC). In presence of metabolic components of fatty-liver-disease (MAFLD), the liver fibrosis progression risk is higher. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a69efa9c01715bfeb049cb5ca415119
https://doi.org/10.1016/j.dld.2022.12.009
https://doi.org/10.1016/j.dld.2022.12.009
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2464 (2022)
Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease that may progress to fibrosis and/or cirrhosis. Treatment options are currently limited. The first-line therapy for this disease is the drug ursodeoxycholic acid (UDCA),
Externí odkaz:
https://doaj.org/article/3d895197c9bb48df89e006194bf98ffe
Autor:
Nora Cazzagon, Samantha Sarcognato, Annarosa Floreani, Giorgia Corrà, Sara De Martin, Vincenza Guzzardo, Francesco Paolo Russo, Maria Guido
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100286- (2021)
Background & Aims: Primary sclerosing cholangitis (PSC) is a rare cholangiopathy of unknown aetiopathogenesis. The aim of this study was to evaluate cellular senescence (CS) marker expression in cholangiocytes of patients with PSC and their correlati
Externí odkaz:
https://doaj.org/article/a5bf4f5405f94c65818e4a344aca2d3c
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 2033 (2022)
Ursodeoxycholic acid (UDCA) is the first-line therapy used for the treatment of PBC. In recent years, new pharmacological agents have been proposed for PBC therapy to cure UDCA-non-responders. Obeticholic acid (OCA) is registered in many countries fo
Externí odkaz:
https://doaj.org/article/c34f5e015ce24f7e8259bc13d9ea95c8
Autor:
Daphne D’Amato, Antonio De Vincentis, Federica Malinverno, Mauro Viganò, Domenico Alvaro, Maurizio Pompili, Antonino Picciotto, Valeria Pace Palitti, Maurizio Russello, Silvia Storato, Marie Graciella Pigozzi, Vincenza Calvaruso, Elisabetta De Gasperi, Ana Lleo, Antonino Castellaneta, Adriano Pellicelli, Nora Cazzagon, Annarosa Floreani, Luigi Muratori, Stefano Fagiuoli, Grazia Anna Niro, Valentina Feletti, Raffaele Cozzolongo, Natalia Terreni, Marco Marzioni, Rinaldo Pellicano, Pietro Pozzoni, Leonardo Baiocchi, Luchino Chessa, Floriano Rosina, Gaetano Bertino, Maria Vinci, Anna Morgando, Ester Vanni, Gaetano Scifo, Rodolfo Sacco, Maria D’Antò, Valentina Bellia, Roberto Boldizzoni, Silvia Casella, Barbara Omazzi, Guido Poggi, Laura Cristoferi, Alessio Gerussi, Vincenzo Ronca, Rosanna Venere, Francesca Ponziani, Maria Cannavò, Alessandro Mussetto, Rosanna Fontana, Francesco Losito, Evelise Frazzetto, Marco Distefano, Francesca Colapietro, Sara Labanca, Giulia Marconi, Giuseppe Grassi, Giovanni Galati, Sarah Elizabeth O’Donnell, Clara Mancuso, Giacomo Mulinacci, Andrea Palermo, Ernesto Claar, Antonio Izzi, Antonio Picardi, Pietro Invernizzi, Marco Carbone, Umberto Vespasiani-Gentilucci
Publikováno v:
JHEP Reports, Vol 3, Iss 2, Pp 100248- (2021)
Background & aims: Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety o
Externí odkaz:
https://doaj.org/article/ae3bd5090ee148768daea8f1e94b4ae4